Clinical Trial Update: Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing flecainide versus amiodarone for cardioversion of paroxysmal atrial fibrillation in patients with coronary artery disease wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation Paroxysmal
• Coronary Artery Disease

Drugs mentioned

• Amiodarone (amiodarone)
• flecainide (flecainide)

Snippet

Sponsor: Hippocration General Hospital | Conditions: Atrial Fibrillation Paroxysmal, Coronary Artery Disease Without Residual Ischemia | Phase 3 | Status: RECRUITING